Secondary Logo

April 2019 - Volume 41 - Issue 2
pp: 107-256

Focus on Pharmacodynamic Drug Monitoring

Absence of Relationship Between Crohn's Disease Activity Index or C-Reactive Protein and Infliximab Exposure Calls for Objective Crohn's Disease Activity Measures for the Evaluation of Treatment Effects at Treatment Failure

Edlund, Helena; Grisic, Ana-Marija; Steenholdt, Casper; More

Therapeutic Drug Monitoring. 41(2):235-242, April 2019.

Different Underlying Mechanism Might Explain the Absence of a Significant Difference in Area Under the Concentration–Time Curve of Linezolid for Different ABCB1 Genotypes

Bolhuis, Mathieu S.; Akkerman, Onno W.; Sturkenboom, Marieke G. G.; More

Therapeutic Drug Monitoring. 41(2):253-254, April 2019.